AIDS, CANCER CURED BY HYPER-OXYGENATION

share page

Share this with your friends

AIDS, CANCER CURED BY HYPER-OXYGENATION

AIDS, Cancer Cured by Hyper-Oxygenation

Several dozen AIDS patients have not only reversed their death sentences, but are now back at work, completely free of the disease. They destroyed the virus in their blood by hyper-oxygenation, known in various forms as oxygen therapy, bio-oxidative therapy or auto-hemotherapy. This is a simple, inexpensive and very broadspectrum healing process that many feel could force a complete overhaul of the medical industry. The two basic types of oxygen therapy are ozone blood infusion, and absorption of oxygen water (hydrogen peroxide) at very low concentrations.

It turns out that the AIDS virus cannot tolerate high oxygen levels in its victims' blood. Not only that, every other disease organism tested so far apparently has the same weakness. Even cancer growths contract and disappear when the oxygen saturation is sufficiently increased in the fluids surrounding them, since they are anaerobic.

AIDS, herpes, hepatitis, Epstein Barr, cytomegalovirus and other lipid-envelope virus are readily destroyed by hyper-oxygenating the patient's blood with ozone. This was demonstrated by, among others, Dr. Horst Kief in Bad Hersfeld, West Germany. Dr. Kiefhas already cured a number of AIDS victims by drawing blood, infusing it with ozone and returning it to the patient, at regular intervals until all the virus is gone. (He can be reached through Biozon Ozon-Technik GmbH, An Der Haune #10, Bad Hersfeld, D-6430, Federal Republic of Germany.) Dr. S. Rilling of Stuttgart and Dr. Renate Viebahn of Iffezheim are among the growing number of physicians who have obtained similar results with their patients. They are with Arztlich Gesellschaft fur Ozontherapie and JrJ Hansler GmbH, respectively.

The Basis of Bio-Oxidative Therapies

For many years the health sciences have been seeking to identify the primary physical cause of all diseases, and the cure-all that this basic principle would yield. Now both have been found, but their utter simplicity makes them difficult to accept at first, since it seems like if it's that easy, we should have been using them all along.

Our bodies are composed mostly of water, which is eight-ninths oxygen. Most nutritional studies tend to get caught up in the small details of biochemistry and overlook our most abundant and essential element, and the fundamental role of its depletion in causing illness. Of all the elements the body needs, only oxygen is in such constant demand that its absence brings death in minutes.

The main difference, for healing purposes, beween benign microorganisms (including our own cells), and those which cause disease, is that the latter require much lower oxygen levels. This is due to their more primitive evolutionary origins, during the ages when free oxygen was far less abundant. Now their descendants can only survive in low-oxygen environments such as accompany stagnation and decay. To become a growth medium for such parasites, one has to have allowed the oxygen saturation of the body's fluids to drop well below the optimum level for healthy cell growth and function.

The simplest substances available for restoring one's oxygen balance to a healthy range are ozone (O(3)), and hydrogen peroxide (H(2)O(2)), which is much easier to obtain and use. These are both highly toxic when concentrated, which has tended to obscure their germicidal value except as a skin antiseptic. But when diluted to therapeutic levels (for H(2)O(2), 1/2 of 1% or less), they are not only nontoxic but uniquely beneficial.

Ozone Blood Treatment

Ozone overcomes the AIDS virus by a fundamentally different process than usually attempted with drugs. Instead of burdening the liver and immune system with more elaborate toxic substances, ozone simply oxidizes the molecules in the shell of the virus.

The treatment is remarkably simple. The ozone is produced by forcing oxygen through a metal tube carrying a 300-volt charge. A pint of blood is drawn from the patient and placed in an infusion bottle. The ozone is then forced into the bottle and mixed in by shaking gently, whereupon the blood turns bright cardinal red. As the ozone molecules dissolve into the blood they give up their third oxygen atom, releasing considerable energy which destroys all lipid-envelope virus, and apparently most other disease organisms as well, while leaving blood cells unharmed.

It also oxygenates the blood to a greater degree than is usually reached, what with poor air and sluggish breathing habits. The treated blood is then given back to the patient. This treatment is given from twice a week to twice a day, depending on how advanced the disease is. The strengthened blood confers some of its virucidal properties to the rest of the patient's blood as it disperses.

The disease will not return, as long as the patient maintains his blood in an oxygen-positive state, through proper breathing, exercise, and clean diet.

A Dr. Preuss, in Stuttgart, has written up ten case histories of AIDS patients he has cured by this method. But his and the other physicians' reports of cures are all anecdotal rather than in the form of "controlled studies," since they could not be expected to treat some patients and deny treatment to others just for the purpose of accumulating evidence. Thus their results are not considered "proof" by the U.S. medical community. So the Medizone Company in New York has taken on the task of doing the controlled studies required for the treatment to be approved in the U.S. for general use.

Medizone Testing Ozone Blood Treatment

Last summer Medizone obtained from the FDA an IND (Investigative New Drug) approval for ozone, which falls under the heading of drugs even though it isn't. They verified that ozone destroys the AIDS virus in vitro, and completed their animal tests in the fall of 1986. The tests demonstrated no indication of toxicity, at ten times the equivalent amount that is proposed for human treatment.

The Medizone Co. is at 123 E. 54th St., Ste. 2B, New York, NY 10022; phone is 212-421-0303.
Medizone was granted U.S. Patent #4,632,980 on December 30, 1986, on "inactivating lipid-envelope viruses in blood that is returned to a mammalian host." In humans, this includes AIDS, herpes, hepatitis, Epstein Barr virus, and cytomegalovirus, among others. Medizone obtained tentative FDA approval in April 1987 to begin human testing, but for a variety of "bureaucratic reasons" the FDA has postponed the actual start of the tests 4 times now, with requests for further data, some of which had already been given to them.

Months have now passed, along with several thousand AIDS victims, since the first announced starting date was postponed. The Medizone staff is hoping to finally begin around November 1st, but are no longer announcing expected starting dates with much confidence. "There are no technical problems, but this is the FDA we're dealing with, after all." As the Company's future hangs on their decision, no one at Medizone wants to risk antagonizing the FDA, by speculating about their actual motives for stalling on a cure for this unprecedented epidemic.

All this has been with virtually no publicity. The official reason for this is that the accepted procedure for publishing medical breakthroughs is to complete all the tests first, even though victims may die waiting for the cautious, methodical testing procedure to run its course. No one in the industry wants to raise false hopes, let alone repeat the medical disasters that have resulted in the past, from rushing approval on new treatments.

On the other hand, the enormously expensive and dubiously effective drug AZT was widely publicized many months before it was approved in the U.S. as is ongoing research into possible AIDS vaccines. In fact, former FDA Commissioner Frank Young has even announced a proposal to make experimental drugs available to AIDS victims as swiftly as possible, without waiting for the full FDA approval procedure to be completed. So there appears to be a severe double standard involved here. It seems that highly profitable "treatments" with serious side effects can be promoted through massive news coverage, while an actual cure, repeatedly demonstrated in Europe, with minimal cost and no apparent harmful effects, must be delayed and kept quiet while panic and deaths mount. Surely at this stage the benefits of unauthorized publicity will outweigh the risks.

Safe Purification of Blood for Transfusions

Ozone infusion also provides a simple method of purifying stored blood and blood components, eliminating any possibility of disease being transmitted by transfusion. It also pre-oxygenates blood to be transfused, greatly reducing the burden on the body receiving the blood.

This application alone, of the Medizone process has enormous profit potential, and the treatment will have vast international demand as the news spreads. This has not gone unnoticed by various investment analysts. Confidential: Report from Zurich, Penny Stock Insider and Low-Priced Stock Edition, among others, are urging their readers to get in on Medizone now, comparing the opportunity to getting in on Zerox, IBM or Polaroid when they were still unknown.
Various physicians have independently discovered ozone to be also effective against cancer, leukemia, arthritis, coronary heart disease, arterial circulation disorders, colitis, gum diseases, and assorted children's diseases. Some of these findings have now been collected and published in the volume, Medical Applications of Ozone, available from the International Ozone Association, 83 Oakwood Terrace, Norwalk, CT 06850.

Some of the medical uses of ozone have been appreciated for years in Europe, Brazil and elsewhere, as well as its advantages over chlorine for water treatment (no toxic residues, 5000 times more rapid disinfection) but it's still relatively unknown in the U.S.

Oxygen Water

A much simpler type of Oxygen Therapy uses hydrogen peroxide (H(2)O(2)), which is what ozone (O(3)) forms on contact with water. It can be taken orally if diluted with water to 1/200 or less, absorbed through the skin by bathing in it (anywhere from 1-8 pints of 3% H(2)O(2) in a standard size bathtub half full), or in severe cases it can be injected (250 cc of .075% to .15%, or roughly 1/1300 to 1/650). Injections obviously require a physician's assistance, but self-treatment is possible with oral and skin applications.

The principle is the same as with ozone blood treatment. All hostile microorganisms prefer lower oxygen levels than the body's cells require to remain healthy. Boosting the oxygen level revitalizes normal cells while killing virus and other pathogens.

The domestic sales of hydrogen peroxide are rising at 15% per year, as the news of this option spreads at the grassroots level. The rapid expansion of the peroxide movement is especially remarkable considering there has been almost no media coverage, and in fact the FDA, American Cancer Society and other enforcers of established medicine have tried hard to discourage the practice.

Hydrogen peroxide is the only germicidal agent composed only of water and oxygen. Like ozone, it kills disease organisms by oxidation as it spreads through the patient's tissues.

This also destroys cancerous growths which are anaerobic. Nobel Prizewinner Dr. Otto Warburg demonstrated over fifty years ago the basic difference between normal cells and cancer cells. Both derive energy from glucose, but the normal cell requires oxygen to combine with the glucose, while cancer cells break down glucose without oxygen, yielding only 1/15 the energy per glucose molecule that a normal cell produces. This is why cancer cells have such a huge appetite for sugar, and also why people who consume excessive quantities of sugar tend to get cancer more often.

The anaerobic breakdown of glucose by cancer cells forms large amounts of lactic acid as a waste product, the same substance formed by fermentation of lactose, as in spoiled milk. The liver converts some of this back into glucose, in an attempt to salvage a food source from a toxic waste. In doing this the liver only uses 1/5 the energy per glucose molecule that a normal cell can then derive from it, but that's three times the energy a cancer cell will get from it. The more the weak, deranged cancer cells multiply, the more energy is lost to the normal cells. Thus we find that low levels of both oxygen and energy tend to occur where cancer is present, and vice versa. This wasteful metabolism becomes self-sustaining and dominant unless the oxygen and/or energy levels are sharply increased, or the cancer's food source eliminated.

Heart Transplant Pioneer Recommends Oxygen Water

Dr. Christiaan Bernard, who performed the first heart transplant, said in March 1986 that he was taking peroxide and water himself, several times daily to reduce arthritis and aging, and he recommended it highly at that time. Since then he has come under heavy attack by the medical establishment for this position, and now states that he "is not involved" with the peroxide movement. But he does not retract his original endorsement, nor deny that he still uses it personally.
Over a hundred physicians are already curing a broad assortment of "incurables" with this natural anti-microbial agent. This includes forty or more in the U.S. A principal liaison to these free-thinking physicians is Dr. Charles H. Farr, who wrote The Therapeutic Use of Intravenous Hydrogen Peroxide. He directs the International Bio-Oxidative Medicine Foundation, and publishes the IBOM Newsletter which contains procedural updates and technical refinements for physicians using intravenous H(2)O(2) therapy on their patients. By classifying the treatments as experimental they can get around the FDA's archaic restrictions for now, until massive public demand and/or media exposure force official approval.

Dr. Farr summarizes the beneficial effects of H(2)O(2) in IBOM issue #2; these include killing bacteria, protozoa, yeast, and virus, oxidizing lipids from arterial walls, increasing oxygen tension intracellularly, stimulating oxidative enzymes, returning elasticity to arterial walls, dilating coronary vessels, and regulating membrane transport. IBOM is at P.O. Box 61767, Dallas/Ft. Worth, TX 75261/ 817-481-9772. Dr. Farr is at 11330 North May Ave., Oklahoma City, OK 73120; 405-752-0070 and 799-8781.

H(2)O(2) Can Be Self-Administered

The oral and skin applications offer the option of home treatment as no blood needs to be drawn, and hydrogen peroxide is cheap and plentiful. Keep it diluted though; in high concentrations it can irritate sensitive skin and induce vomiting when ingested. (Veterinarians routinely give common 3% H(2)O(2) to animals that have swallowed poison, to make them throw it up.)

The starting dosage is one ounce of .5% (1/200) H(2)O(2) in water, and some will find they need to start with less. As the peroxide contacts pathogens in the stomach it liberates free oxygen, so those with high levels of virus and streptococcus in their stomachs may feel slight nausea while the reaction is occurring. The dosage is increased by an ounce per day, up to five ounces on the fifth day, then finally up to five ounces three times daily for a week (or until disease is no longer present). Then the dosage is tapered back down over a five-week period.

Food-grade or Re-agent (these are 35%, dangerous if undiluted) is better for internal use since the common USP 3% H(2)O(2) contains small amounts of chemical stabilizers and other impurities. It can still be used if foodgrade is unavailable; it just isn't as pure.

An alternate dosage regimen uses three drops of 35% H(2)O(2) in a glass of water, three times a day, which is then increased by a drop per dose, per day, up to 25 drops per dose in extreme cases. Candidiasis victims should start at one drop per dose, and build their tolerance gradually. Some find the taste rather bleachy and unpleasant, and may wish to chase it with plain water. It can also be mixed with fruit juice, and citrus juices in particular cover the taste pretty well.
Adding seven drops of 35% H(2)O(2) to a gallon of drinking water and shaking well purifies it and gives it a pleasant waterfall-like flavor.

For more dosage details and extensive references on H(2)O(2) taken internally, contact Walter Grotz, Box 126, Delano, MN 55328/ 612-972-2144. His progress report, Echo, costs $1. He provided much of the material regarding H(2)O(2) in this article. Another source is Father Richard Wilhelm, Box 18, Union Rd., California, KY 41007; 606-635-9297. These gentlemen have continued the research initiated by Dr. Edward Carl Rosenow (1875-1966). They have located over 4000 peer-reviewed medical articles on the applications of hydrogen peroxide, some dating back to the 1800's. They received the National Health Federation's Pioneer Award in Medicine three years ago for this ongoing research. Walter Grotz, in particular, has been touring and lecturing extensively on the benefits of self-administered H(2)O(2), literally saving lives wherever he goes, and bringing hope to people who had been told their cases were hopeless.

Dr. Kurt W. Donsbach at the Bio-Genesis Institute in Rosarita Beach, Baja Mexico (619-428-8585), has achieved a remission rate exceeding 70% in over 300 patients, at last count, most of whom had been previously told they were beyond hope, and had "tried everything else." Bio-oxidative therapies are now applied to all cases that arrive at this clinic, and all respond except for some of those who arrive already very close to death. The Guadalajara Medical School, Mexico's largest, is initiating their own tests this summer, and will add it to their curriculum upon verification.

As Dr. Donsbach has pointed out, no U.S. clinic or institution has ever tested intravenous H(2)O(2) as a treatment for cancer, so any claim that it is not effective is not based on clinical trial, and amount to willful disinformation.
The Gerson Institute and La Gloria Clinic in Mexico are also using hydrogen peroxide therapies on their patients, after the staff tested it on themselves and found it to be beneficial.

Hydrogen Peroxide in Nature

Hydrogen peroxide occurs naturally in rain and snow, from atmospheric ozone, and in mountain streams where rushing water is continuously aerated. Most of us learned at an early age to drink from a stream only where the water's running white, because that's where it gets cleansed of germs. The reason is that H(2)O(2) is forming there due to the water's rapid agitation, and that's what kills any harmful microbes present.

It turns out that the spring waters at Lourdes, France, long recognized for their remarkable healing properties, are very high in natural hydrogen peroxide. The spring is fed by high-altitude snowmelt, so the snow apparently absorbs unusually large quantities of ozone on its way from the upper atmosphere. Other less-known high altitude springs are said to be likewise effective.

Similar benefits can be obtained in a swimming pool or hot tub, by discarding the chlorination system and simply pouring in H(2)O(2), or by bubbling ozone through the water. One simple method of making poolgrade ozone is to pump air past an enclosed ultra-violet lamp.
Raw, uncooked vegetables and fruits contain natural hydrogen peroxide. Cooking drives off the extra oxygen. Fresh fruit juices are well known for their blood-cleansing and revitalizing capabilities, particularly when they are not combined with other foods; this is largely due to the H(2)O(2) they contain. Reconstituted frozen juices have much less, and are no longer "alive," thus they are not nearly as effective.

H(2)O(2) is Heart of Immune System

Mother's milk contains a high amount of H(2)O(2), especially colostrum, the first milk secreted after birth, which activates the newborn's immune system. H(2)O(2) is the first line of the body's defense systems, and key to many other metabolic processes.

Under conditions of optimum health, H(2)O(2) is produced by the body's immune system in whatever amounts are needed to quickly destroy any invading hostile organisms. It is made by combining water in the body with the free oxygen that is supposed to be constantly available. When the body is oxygen-starved, it can't produce enough H(2)O(2) to wipe out invading pathogens, which can then get the upper hand and cause visible disease.

Oxygen Boost is Key to Other Healing Methods

When penicillin is effective against infection, it is largely due to the formation of bactericidal amounts of H(2)O(2), when glucose is oxidized by O(2) in the presence of penicillium notatin. (General Biochemistry, Fruton & Simmonds 577.1 F944 p. 339)

Much has been made of the healing properties of Interferon, but it is unbelievably expensive. However, much of its effectiveness is apparently due to the fact that it stimulates production of H(2)O(2) and other oxygen intermediates, which are a key factor in reactivating the immune system. (Journal of Interferon Research Vol. 3, #2, 1983 p. 143-151.) Thus Interferon may turn out to be simply a very elaborate way to accomplish essentially the same thing as the H(2)O(2) regimen.

Vitamin C (ascorbic acid) has long been recognized as essential to the proper use of oxygen by the cells. Dr. Linus Pauling has demonstrated that large doses of vitamin C are effective against cancer. The mainstream medical community still has not acknowledged this discovery, let alone put it to use, despite Dr. Pauling's credentials. As it turns out, vitamin C actually creates extra H(2)O(2) in the body.

Organic Germanium (bis-carboxyethyl germanium sesquioxide) is gaining increasing recognition as a potent healing substance, primarily through the work of Dr. Kazuhiko Asai. This compound directly increases the body's oxygen supply, as it contains a great deal of oxygen in a form that can be easily assimilated.

Taheebo (aka Pau D'Arco or Lapacho Colorado) is a tree that grows in the Andes and fixes high concentrations of oxygen in crystalline form into its inner bark. The bark has been used for centuries by the native peoples of the area to prevent and reverse illnesses, and it is one reason why they do not get cancer. In recent years it has become popular in the U.S., and it gets by the FDA as an "herbal tea" whose distributors wisely make no medical claims for it. Again, much of its effectiveness is apparently due to its high oxygen content, released in solution when brewed as a tea.

Causes of Oxygen Depletion

There are several very common practices that drop a person's oxygen level far below where it should ideally be. At sea level, 20% of the atmosphere is supposed to be oxygen, but city air goes down as low as 10%, due to smog and removal of trees. Air that tastes bad induces a tendency to breathe shallowly, getting even less oxygen to the blood. So does lack of exercise.

The carbon monoxide (CO) in smog does not normally occur in nature in much quantity since it's formed by incomplete combustion of carbon compounds. It is electrically unbalanced, so it seeks to bond with any available oxygen to form the more stable carbon dioxide (CO(2)). Those who breathe too much carbon monoxide tend to die fast or slow depending on the concentration. It strips oxygen molecules from the blood to form CO(2), which the body can't use and must exhale, at least until its oxygen runs out. The fact that the body considers CO(2) a waste product, by the way, doesn't say much for carbonated beverages.

Tap water is very low in oxygen, having had no opportunity to be aerated during its journey through the pipes, and being loaded down with chlorine and various contaminants. Since cooking drives the extra oxygen out of vegetables, if one's diet is mostly cooked or processed foods, there's yet another oxygen source lost.

Eating, Fasting and Oxygen Balance

Overeating is so common in the U.S. it's considered "normal." One cause is the widespread use of oral antibiotics. While destroying the target germs, these drugs also kill off one's intestinal flora, which are needed for healthy digestion. With these friendly bacteria gone, digestive efficiency plummets. As a result, the sensation of hunger comes more often and lasts longer, as the body tries to compensate for ineffective digestion by increasing the amounts consumed.

Even just eating daily, without ever giving the gastro-intestinal tract a rest, loads down the blood with toxins and impurities, especially uric acid crystals. Under a microscope these resemble tiny coffin-lids, interestingly enough, another clue to our Creator's whimsical sense of humor. When the waste products exceed the cleansing capacity of the kidneys, the blood ends up having to just haul it around the body and stash it wherever possible. These toxins literally take up so much room in the blood cells that the cells can't take on enough oxygen when they pass through the lungs. The blood's primary function of picking up and distributing oxygen gets blocked by overuse of the garbage-hauling function.

Fasting restores health by giving the overloaded blood cells a chance to dump the toxins and inert matter through normal organs of elimination at a rate they can handle, instead of through the skin, as in acne, or other inappropriate places. If the fast is long enough, accumulated residues in the body are also scoured out and expelled, giving a considerable spiritual resurgence once all the backlog is cleared away. While the debris is flushing out, various toxic reactions may come and go. Once the blood is cleansed the red corpuscles have a lot more room for oxygen molecules, the oxygen saturation of the tissues is high, and health and energy are boosted considerably. Each breath now gives more life than it was able to in the blood's earlier state.

Most long-lived native peoples, who are not affected by our more common diseases, either include fasting as a regular part of their yearly food cycles, or eat much less overall, than I industrialized peoples.

Today many Americans are existing at such high levels of toxicity, that their toxic reactions when attempting to fast can seem intense enough to make them start eating again before any serious cleansing can be accomplished. Fortunately one can partially bypass the lungs and get the blood oxygen level back up, by taking oxygenated water internally and through the skin. Several weeks of detoxification with this regimen will also make it much easier to fast without discomfort, if one chooses. It reduces appetite, logically enough, to a level more in line with the body's actual needs.
The bacteria that aid digestion are not killed by oral use of H(2)O(2), as long as it's diluted properly.

Oxywater May Even Cure Stupidity

Perhaps the greatest potential benefit is the reversal of the slight brain damage caused by long-term oxygen depletion, which can be observed in the "average" human, and is sometimes not all that slight. It's well known that after about 9 minutes of no oxygen, from drowning or whatever, you can kiss your brain goodbye. But the implications of constant gradual oxygen starvation in our cities somehow escape notice, despite the tiredness, depression, irritability, poor judgement and health problems affecting so many citizens.
Increasing the oxygen supply to the brain and nervous system will reverse these conditions. The oxywater regimen improves alertness, reflexes, memory and apparently intelligence, and may offer the eledery a new weapon against senility and related disorders. Alzheimer's and Parkinson's are reported to be responding to it. Alcoholics who start taking H(2)O(2) soon lose interest in alcohol, and the thirst does not come back. Look up what alcohol does with your blood oxygen and your ability to use it, and you'll see why.

One possible spin-off of a coming major increase in the blood oxygen supply to human brains is that various short-sighted oxygen-depleting activities such as deforestation, and other unintelligent practices, should fade from the scene. Americans especially, will have an opportunity to outgrow many stupid things.

It's strange that the common drug aspirin "stops pain" by interfering with the nervous systems' ability to use oxygen, in the electrochemical reactions needed to transmit impulses. Though maybe it's not that strange, considering that the Bayer Company which originated it was a subsidiary of IG Farben, the German chemical conglomerate that is famous for, among other things, developing and mass-producing the lethal gas Zyklon-B specifically for exterminations at Nazi death camps.

Economic Inertia

Dr. Terry McGrath, the CEO at Medizone, confirmed that hydrogen peroxide would in principle act much like ozone in destroying the AIDS virus, but pointed out that it's never likely to be tested and proven in the laboratory. There's simply no economic incentive, since it's an unpatentable process and offers no more commercial returns than most other natural remedies. So it's completely up to individual patients and concerned citizens to push these options out into the open, immediately, before various companies get too financially committed to the assumption that AIDS (or any other disease) will continue to spread and be incurable.

This is as good a place as any for the FDA-required disclaimer: "Information given here is for research and educational purposes only and is not intended to prescribe treatment."

Veterinary and Agricultural Applications

Humans aren't the only life form that benefits from compensation for their oxygen-deficient air, water and/or lifestyle. H(2)O(2) in animals' drinking water, not enough to taste unpleasant, knocks out a growing list of illnesses. Locally, cats have gotten rid of their feline leukemia and chlamydia, and are back to their old energetic slapstick selves. Distemper in dogs has been reversed with H(2)O(2), and a growing number of farmers are applying it to their livestock to cut losses from disease and infected wounds.

Plants grow better with an ounce of 3% H(2)O(2) per quart of water they're given. Spray the solution on their leaves as well. Seeds geminate faster, with bigger sprouts, when they are first soaked in 1 ounce of 3% H(2)O(2) to a pint of water. Instead of cutting trees that are diseased or otherwise struggling, spray them with H(2)O(2) and water (1 part 3% to 32 parts water).

Why Isn't This Already In Use?

The obvious question is, if hyperoxygenation is so simple and effective, why has it taken so long to discover it? Ozone is hardly new and hydrogen peroxide has been on the market for over a century. Why aren't all the doctors already using it? How come this stow isn't all over the major news outlets?

Turning the question around helps clarify the problem. Just exactly what would happen if a cure was discovered that was completely effective against the vast majority of diseases, ridiculously cheap and plentiful, and in most cases could be selfadministered without a physician?

Would the current medical establishment welcome a breakthrough that could render 98% of all drugs, testing and diseaserelated surgery obsolete? What would the response be of the pharmaceutical industrialists, hospital chain owners, health insurance moguls, AMA, and FDA?

Would you expect to read or hear such an announcement from any medical journal or media outlet owned by people financially committed to the medical status quo, which is practically all of them? How many want to help their own occupation become unnecessary?

And if the cure had already been suppressed once, wouldn't the possible blame for allowing people to die without it provide even more incentive to continue keeping the whole thing quiet?

All right then. This is precisely the situation that exists, and the cure has indeed been around for ages. It has been independently reported effective against virtually every disease at one time or another, in thousands of public-domain medical articles, which had never been collected and correlated until recently. And it is so simple and basic that concealing it from most physicians and the general public has required a tremendous smokescreen of artificial complications, narrow specializations, symptomatic classifications and userhostile treatments.

If this is so, it follows that the more profit-fixated elements of the medical establishment will not be too thrilled about the recent surge of interest in oxygen therapies. The drug industry has expanded enormously since WWII, while America's level of health has dropped from the world's highest to the lowest among the industrialized nations. It does look as if the bottom line has been money and not health, for a long time.

The battle for the future of medicine, between Nature's truth and lucrative lies, is about to really heat up. We can expect to see disinformation articles and newscasts with persuasive medical experts, some of whom will even believe what they're saying, warning of the dangers of hydrogen peroxide, ozone, and even regular oxygen. These reports will attempt to blur the distinction between using therapeutic dosages at safe dilutions, and the harmful effects of excessive concentrations. Plenty of grisly examples are available, of what happens when various tissues are over-oxidized.
Anti-oxygenation propaganda pieces will probably not mention that over the years the FDA has approved H(2)O(2) as a skin antiseptic at full 3% strength, as a hair bleaching agent at 6%, and for internal use as an additive to milk and in aseptic long-shelf-life packaging. Nor are they likely to acknowledge that many European countries use ozone and H(2)O(2) in their cities' water supply, and that they enjoy much better health than in the U.S. And they will be unable to truthfully cite any examples of people who were harmed by using H(2)O(2) in the correct demonstrated therapeutic concentrations.
It is vital for Americans to realize the current economic dynamics don't allow the businessmen in charge of the health industry any incentive at all, to make people permanently healthy and lose them as customers. It's the same reason why the energy conglomerates do not encourage citizens to become energy-self-sufficient, the Pentagon has no incentive to stop wars, and the American Psychiatric Association sees no advantage to ending mental illness.

Fortunate]y, the majority of physicians really do want to see their patients get well. They also wouldn't mind regaining the respect and admiration with which physicians were once more widely regarded. When it comes down to a choice between saving lives and protecting profits, most will be brave enough to overhaul their medical belief systems, discard obsolete methodologies, and basically tell the pharmaceutical conglomerates to go shove it. The rest will simply get left behind.

Sources For Food-Grade Hydrogen Peroxide

Most pharmacists have never even heard of it, so it's usually a waste of time to ask them. A number of chemical supply houses have 35% H(2)O(2) available; check your local directories and call a few. Under FDA pressure, DuPont and possibly other major chemical companies have recently issued warnings to their distributors, not to sell hydrogen peroxide to people who want it for healing purposes. So when you inquire, if they ask what you want it for, it will unfortunately be necessary to lie. If you say you want it as a cleaning agent, that's at least pretty close to the truth.
Several physicians quietly sell it through the mail, but they aren't the same ones promoting its healing properties, for obvious FDA-related reasons. A good source in California, though he can ship it anywhere, is Dr. A.J. McDonald, at P.O. Box 775, Lodi, CA 95240; 209-368-8681/ $12/pint.

Your best move would be to share this information with owners of health-food stores in your area. Call them and ask if they have food-grade H(2)O(2) (some already do) and tell them why you want it and how it works. Encourage them to carry it and give them Dr. McDonald's address if they don't seem inclined to track down a local source.

Cleanroom-grade 30% H(2)O(2) (used for cleaning in computer rooms since it is a powerful disinfectant and leaves no residue when it evaporates) is reported to be just as pure as foodgrade and much cheaper. Check with labs that make "wafer fabrication" chemicals, or contact the manufacturers of silicon chips and other computer parts, and the data processing complexes that might use it in their cleanrooms, and ask where they buy it. The more sources become known, the harder it will be for anyone to make it unavailable.

Get the Word Out

Write your elected officials, send copies of this information, and point out what will happen to a politician whose constituents learn he knew of a cure for cancer and AIDS but didn't tell them about it. Call in on radio talk shows and share the good news, or send copies to their reporters and program directors, especially at listener-supported stations as these are less likely to suppress it. Don't assume your local papers have already heard of this; write letters to editors, and/or send copies of this report. Tack it up on every bulletin board you see, and post it on all relevant computer bulletin boards.

If you know teachers, physicians, or health officials who can still think for themselves, tell them about this and give the references. Notify your local police officials that hyperoxygenation gives them a way of making sure they'll be safe from infection due to contact with AIDS carriers. If you're really feeling bold, walk into the local hospital's cancer wards and hand a copy of this report to anyone who can still read, and slip out the back door before their doctors walk in. Share it with anyone you know who has a health problem, even a minor one; H(2)O(2) apparently works on everything from acne to warts.

Above all, stop buying the idea that cancer, AIDS, and other "terminal" illnesses are automatic death sentences. When you hear some celebrity you like is sick or dying of this or that, look up their mailing address in Who's Who or whatever, and mail them this information. If the address is for an agent, who are notorious for blocking attempted communications to their client, you might include a cover letter, stating that the enclosed vital news is also being sent to their client's family members, and that if he or she learns through them that there was life-saving information sent but held up at the agent's, that agent will be out of a job. Act like you have the clout it takes to make a difference, and you soon will.
Major scientific breakthroughs go through three stages; first they are ridiculed, then violently opposed, and finally they are accepted as having been self-evident all along. Let's see if we can short-cut those first two stages a bit, OK?

Further Information Sources:

Echo, a newsletter on Oxygen Therapy, is available from Walter Grotz, Box 126, Delano, MN 55328, ($2, 8p); 612-972-2144. He and Father Richard Wilhelm (Box 18, Union Rd., California, KY 41007; 606-635-9297) have extensive references and case histories of successful treatments.

The Peroxide Story, George L. Borell, 3035 Rome Ave., Anaheim, CA 92804; 60p, $4.95 plus $1 postage.
The International Bio-Oxidative Medicine Foundation (IBOM) Newsletter contains technical updates for physicians using H(2)O(2) therapies on their patients. P.O. Box 61767, Dallas/ Ft. Worth, TX 75261; 817-481-9772.

Rex Research (P.O. Box 1258, Berkeley, CA 94701) has five folios on Ozone Therapy: #4 ($2, 10pp) is specifically on ozone treatment of AIDS; see also #1, ozone vs. a wide variety of conditions ($6, 55pp); #2, ozone vs. herpes, hepatitis, rheumatic diseases, also dental use ($4, 29pp); #3 cardiovascular, ozone enrichment of blood prior to transfusion ($4, 23pp) and Ozone vs. Cancer ($6, 55pp).

The International Ozone Association, 83 Oakwood Ave., Norwalk, CT 06850; 203-847-8169) has available Medical Applications of Ozone the largest single volume on the subject, for $50.

Self-Treatment for AIDS: Oxygen Therapy ($12.95, 100pp), and Home Remedies for Candida ($8.95, 112pp) consist mostly of article reprints, compiled by Betsy Manning, 1600 Larkin #104, S.F., CA 94109.

Search For Health, APW, P.O. Box 3052, Iowa City, Iowa 52244. Tom Valentine, Editor. Includes info on other oxygenating compounds for internal use, including AEROX, which they sell, and which is reported to give the same benefits as H(2)0(2), but tastes better and is more stable, though more expensive. (We have not yet obtained a sample for testing.) APW also is a source for full-spectrum health-enhancing KIVA lights.

Some of the formal medical articles on H(2)O(2) include: "Hydrogen peroxide mediated killing of bacteria," D.P. Clifford and J.E. Repine, (Molecular and Cellular Biochemistry 49, 143149, 1982); "Generation of H(2)O(2) in Biomembranes," T. Ramasarma, (Biochemica et Biophysica Acta, 694, 1982, 69-93); "Removal of Cholesterol and Other Lipids from Experimental Animal and Human Atheromatous Arteries by Dilute Hydrogen Peroxide," James W. Finney, Bruce E. Jay, et al., (Baylor University Medical Center, Dallas, Texas); also a series on the role of H(2)O(2) in immunity to malaria, in The Lancet, 12/25/82 p. 1431-1433, 1/29/83 p. 234, and 2/12/83 p. 359-360.

Medizone International, 123 East 54th St., Suite 2B, New York, NY 10022; 212-421-0303; issues shareholder reports updating the stateside verification of ozone blood treatment. Hansler ozone generators will also be available to licensed physicians through Medizone.

Biozon Technik Co. in Bad Hersfeld, Federal Republic of Germany, also makes ozone generators for medical use.
Article copyright Townsend Letter for Doctors & Patients.

Share this with your friends

The Discovery
In the Fall of 1990, two medical researchers, Drs.William Lyman and Steven Kaali, working at Albert Einstein College of Medicine in New York City made an important discovery. They found that they could inactivate the HIV virus by applying a low voltage direct current electrical potential with an extremely small current flow to AIDS infected blood in a test tube. Initially, they discovered this in the lab by inserting two platinum electrodes into a glass tube filled with HIV-1 (type 1) infected blood. They applied a direct current to the electrodes and found that a current flow in the range of 50-100 microamperes (uA) produced the most effective results. Practically all of the HIV viral particles were adversely affected while normal blood cells remained unharmed. The viral particles were not directly destroyed by the electric current, but rather the outer protein coating of the virus was affected in such a way as to prevent the virus from producing reverse transcriptase, a necessary enzyme needed by the virus to invade human cells. Reverse transcriptase allows the virus to enter a human T cell line (called CEM-SS) and commandeer the DNA reproduction machinery. After using the host cell to reproduce itself into thousands of new virii, the swollen host cell (now called syncytia or giant cell) will burst and spew the contents into the bloodstream or lymph system. This is how the virus spreads, but lacking reverse transcriptase, the HIV virus can't invade the host cell and it becomes vulnerable to destruction by the body's immune system. (The details of this experiment can be read from Kaali's patent application.)

Getting the Word Out?
A brief announcement of this discovery appeared in The Houston Post (Mar 20, 1991), then in Science News (Mar. 30, 1991 pg. 207) and later in Longevitymagazine: (Dec.1992 pg. 14). Following their work in the Fall of 1990, Kaali and Lyman presented their findings at the First International Symposium on Combination Therapies (an AIDS conference) in Washington DC on March 14th, 1991. Kaali outlined two methods for treating an AIDS patient with this new therapy: One method involved removing a small amount of blood, electrifying it and then returning it to the patient's body. The second method involved sewing a miniature electrifying power supply along with two tiny electrodes directly into the lumen of an artery. For long term treatment, the mini electrifying unit needed to be removed and relocated to a new artery site after 30-45 days since scar tissue and calcification forming around the implant unit would lead to artery blockage. Kaali (along with co-inventorPeter Schwolsky) filed for a patent on this implantable electrifying device on Nov 16, 1990 and nine months later was granted patent #5,139,684 on August 18, 1992. It's interesting to note two things here:

1. In order to obtain a patent from the United States Patent Office, Kaali and Schwolsky had to prove that the device works as claimed. Lacking solid proof, US patents are simply not granted.

2. Very often it takes years to obtain a patent, yet this patent was granted in only nine months; a further indication to me of the strength of their demonstrated claims

It's also interesting to note that other than the 3 publications mentioned above and the March '91 AIDS conference, nothing again appeared in print, radio, or TV about this important discovery as a potential treatment and cure for AIDS from Kaali and company. Most knowledgeable observers feel that Kaali and Lyman's discovery was intentionally suppressed following the March '91 AIDS conference presentation. If AIDS research was on the level and not the sham that it actually is, this should have made front page news around the world. (Around 1999, I was contacted by a woman with AIDS who had managed to reach Dr. William Lyman over the phone. She asked him about his experiments with Kaali regarding blood electrification and if she could obtain the treatment through them. Lyman denied any knowledge of any AIDS treatment or cure. He said he never heard of Dr. Kaali and he had no idea what she was talking about concerning blood electrification and then hung up on her. What does that tell about the power of the people behind the suppression of this discovery?)

Enter Dr Bob Beck
A man named Walter Schnitder drew Dr Robert C. Beck'sattention to the above-mentioned item in Science News. Beck looked up the patent and decided to try and duplicate the therapy, but he wanted to do it non-invasively; that is by applying the electric current from outside the body. Now if you apply a direct current (DC) potential to the skin, you're going to get an electrolysis effect and that can cause problems, so Beck designed a circuit that varied the voltage with an alternating current (AC) at a very low frequency and avoided the electrolysis problem. The waveform that Beck chose is not the typical sine wave seen in AC household outlets, but rather is a bi-phasic square wave, meaning that the waveform voltage has a positive half and a negative half, allowing the current to reverse direction each half cycle. Square waves generate a large number of harmonics. Harmonics are frequency multiples of the original frequency. Odd harmonics are mutibles of the original frequency multiplied by 3, 5, 7 etc. and even harmonics are multibles of 2. For example, the odd harmonics of a 4 Hertz (Hz) square wave would be 12 Hz , 20 Hz, 28 Hz, etc. right up into the radio frequency range.

Georges Lakhovsky, Nikola Tesla and many other scientists had discovered that everything in Nature has its own resonant frequency including every bacteria, virus, parasite, and fungus on the planet. Dr. Royal Rife was able to cure terminal, end stage cancers in the 1930's by applying the specific resonant frequencies of certain unique bacteria that are always assocaited wtih all types of cancers. The steady application of the bacteria's resonant frequency by plasma wave radiation caused the bacteria to internally shatter and eviscerate, thus destroying it (and all the other bacteria within the body that possessed the same resonant frequency) .

While Kaali and Lyman used DC current to deactivate the AIDS virus, Beck found that he could get he same results using the 3.92HZ square wave. Kaali and Lyman found that the amount of the current applied was the critcal factor and if they kept the current within a range of 50-100 micro amperes- they were able to disable the HIV virus within a petri dish as mentioned above. Kaali then worked out a design of a small battery with two tiny electrodes that could be sewn directly into an artery in the arm or leg. By maintaining the current flow between the two electrodes within the 50-100 micro ampere range, the HIV particles were gradually disabled within the bloodstream and the AIDS victim would gradually recover his health. The procedure required surgery that costs about $5,000 (at that time). The implanted electrodes would cause scarring of the artery walls, so they had to be removed and implanted in a new section of an artery every month or so, costing another $5,000 each time the procedure was done. It took about 6 or 7 months to see a substantial improvement in the AIDS patient.

Beck studied Kaali's patent and tried applying the electrodes to the skin directly over those arteries that were close enough to the skin surface. The 50-100 micro ampere current could be created within the artery by electromagnetic induction allowing the entire therapy to be applied externally, without the need for implanting electrodes into the arteries. The device he put together to accomplish this is today called a blood electrifier.

Beck started by applying his blood electrifier to himself. He originally placed the electrodes over leg arteries near the ankles of either leg, then changed the location to two different spots on the arm, and finally found that it worked just as well if he placed the two electrodes near each other over the ulnar and radial arteries just behind the wrist. To find the correct location in order to center the electrodes exactly over the artieries, Bob recommends carefully feeling for the pulse of either artery and marking the path of the artery with a ball point pen. You can then memorize the correct location and align the electrodes over the artery path precisely and hold them in place with a stretchy wrist band that's held together with velcro.

Beck Breakfast Group
Bob Beck has been giving talks for many, many years on a variety of topics from Tesla to psychotronics. I first heard him in 1994 on an after-midnight radio show out of Los Angeles called "Something's Happening" with Roy of Hollywood ( KPFK, 90.7 FM). Bob was getting ready to give a talk at the Pasadena Health Expo that upcoming weekend and proceeded to explain to Roy what he had discovered with blood electrification. I was amazed and blown away by what he told Roy. I had to learn more, so I made it my business to be at that convention and attend Bob's talk.

Biocompatible Electric Current Attentuates HIV Infectivity

[From Ken Adachi, Editor: This is an extremely important report for anyone who is concerned about treating AIDS or HIV infection. Photos of the five pages of this 1996 report which appeared in Surgical Overview, Surgical Technology International V, were sent to me by a very sharp scientist and humanitarian named Webster Kehr on November 18, 2006. Webster deserves real credit for finding this published report as much effort has been expended to suppress this Kaali and Lyman 1990 discovery at the Albert Einstein College of Medicine in New York City. For example, Dr. Bob Beck found that the text of the March 1991 Washington DC AIDS conference where Kalii and Lyman first presented their findings publicly, were razor cut out of library copies of the published journal. Bob was able to find only three brief news items immediately following the March AIDS conference in The Houston Post (Mar 20, 1991), Science News (Mar. 30, 1991 ) and Longevity magazine: and then nothing.

The Discovery of the Century to address the greatest bio-engineered 'disease' in modern history, AIDS, was on the receiving end of one of biggest media blackouts ever to be perpetrated on the American public. How many people, to this day, still believe that AIDS is 'incurable'? About 99.999% of the public I would guess.

To make the report readable, I had to enlarge Webster's photos using Photoshop so I could read it and then typed out the text of the report. I've inserted the graphs from the photos of the report into the typed version seen below. This report is a more refined presentation than that provided by Dr. Steven Kaali in his 1992 U.S. patent application (#5,139,684 Kaali & Schwolsky 8-18-92) which I posted to www.educate-yourself.org in January of 2000 (http://educate-yourself.org/be/bekaaliexperiment.shtml).

This discovery by Kaali and Lyman in the Fall of 1990 was the centerpiece of Dr. Bob Beck's lectures on blood electrification. Kaali and Lyman re-discovered something that Dr. Robert O. Becker had also came upon in the 1970's and 80's in that direct current applied at very low voltage, delivered in the 50-100 microampere range effected amazing cellular response and achieved the de-activation of pathogenic organisms.

Kaali and Lyman patented an invasive procedure to insert the DC micro currents. They opened up an artery and sewed in a tiny battery driven circuit with two tiny electrodes within the artery itself. After the battery ran out, they would remove it and insert a fresh unit in another artery location. After 5 or 6 months, the patient showed greatly lowered HIV viral loads and steadily recovered. Bob Beck, on the other hand, invented a non-invasive method of inducing the micro currents electro-magnetically by applying external electrodes to the wrists and used a bi-phasic square wave of 3.92Hz to achieve the same thing as Kaali and Lyman with their internal arrangement. Bob called it "blood electrification" and his unit is called a "blood electrifier" (you can make your own from instructions passed out freely by Bob Beck or get a factory made unit. Contact me for more information).

An important consideration when applying DC (direct current) voltage to the body involves the physics of electrolysis. Dr. Robert O. Becker found that DC voltages higher than 1.1 volt caused sufficient electrolysis action that the body became overwhelmed and produced electrolysis 'waste' products in the region where the DC voltage was applied. Bob Beck got around the electrolysis problem by using an AC (alternating current) voltage in the form of a bi-phasic (two phase, positive and negative) square wave. However, Dr. Hulda Clark is adamantly opposed to using any application of negative voltage, whether as pure negative DC voltage or the negative half of an AC waveform (including the negative half cycle of a bi-phasic square wave). Hulda found that the slightest amount of negative voltage will encourage the growth of pathogenic organisms; something we're trying to avoid.

For those who wish to experiment, you could insert a solid state diode rectifier in series on the "hot" side of the electrode wiring (the other electrode is at "ground" or zero potential) of the Beck electrifier and have the anode of the diode connect to the electrode itself. The diode rectifier will cut off the negative excursion of the Beck bi-phasic electrifier and leave you with only positive pulsing DC square waves. The square wave pulses are only "on" for 50% of each cycle and "off" for the remaining 50%. The 50% "off time" may prevent the electrolysis problem, but that's just a theoretical conjecture on my part. I haven't done any experiments to confirm this one way or the other. Another possible approach is to reduce the pulsing square wave down to a very narrow duty cycle pulse of say 20% . A third possibility is to switch over to a very sharp rise pulse. A possible downside in using a narrow pulse is that it might not deliver the requisite 50-100 microampere current desired, however, it might do it -if only momentarily. There's much food for thought here and an open invitation to anyone who can still think outside the Establishment box, to get busy and see what marvelous results you can obtain by following in the footsteps of both Dr. Robert C. Beck and Dr. Robert O. Becker.

A few notes on nomenclature used in this report:

1. "sup.2" refers to 'supra' (above) or raised to the power of 2 (or squared); so 10cm sup.2 = 10centimeters squared. Another example, "10 sup.5" equals 10 raised to the 5th power (100,000).
2. "sub.2" refers to the number 2 appearing below the letter in front of it as seen with H2O
3. "In vitro" means that the test was made in a test tube or petri dish outside of the body.
4. "In vivo" refers to conditions inside the body.
5. "uL" = micro liters
6. "uA" = micro amperes.
7. "p" = "parts" and "<" = "greater than"

In a few places, I couldn't determine the correct number due to glare in the photo or a bad viewing angle so I had to place a question mark in parentheses (?). If you want to see the reference noted, click on the small number linked in parentheses and you'll go directly to the reference note. To get back to the same place where you were reading, hit the "back" button/arrow.

Sincerely, .Ken Adachi]

© Copyright 2006 Educate-Yourself.org All Rights Reserved.

By William D. Lyman, Ph.D and Steven G. Kaali, M.D, Albert Einstein College of Medicine
http://educate-yourself.org/cn/LymanKaalibiocompatibleHIV1996report18nov...
Posted November 18, 2006

Subject: Kaali and Lyman Paper
From: Webster Kehr
Date: Sat, November 18, 2006 7:39 am
To: Editor of www.educate-yourself.org

Gentlemen:

In 1990, the greatest discovery in the history of medicine took place, the discovery of the cure for AIDS/HIV and very other microbe caused disease on earth. They should have won the Nobel Prize, but their discovery was crushed. However, the two medical doctors involved, Kaali and Lyman, found ways to make their discovery public. They filed several patents, as did several others. While their original paper is lost to the world,.in 1996
they quietly got it republished in a very obscure journal. Their discovery was the basis for the Bob Beck Protocol. I have obtained a copy of the
article and am sending it to you in 5 different emails, one email for each page. Please keep these 5 files in a permanent location and let me know you
got all 5 of them.

Regards,
Webster

****
Biocompatible Electric Current Attentuates HIV Infectivity

William D. Lyman, Ph.D., Professor
Depart of Pathology
Albert Einstein College of Medicine
Bronx, New York

Irwin R. Merkatz, M.D., Professor and Chairman
Steven G. Kaali, M.D., F.A.C.O.G., Clinical Asociate Professor
Department of Ovstetrics and Gynecology
Albert Einstein College of Medicine
Bronx, New York

Introduction

The number of individuals infected by the human immunodeficiency virus type-1 (HIV) continues to increase on a world wide basis. (1) A significant percentage, if not all, of these individuals will eventually develop the acquired immunodeficiency syndromes (AIDS).(2) While horizontal transmission in the homosexual population may be contained or decreasing,(3) heterosexual transmission and infection through contaminated blood supplies continues to increase. (4) Additionally, vertical transmission from infected females to their fetuses is also on the rise with a resultant increase in the number of children with AIDS.(5) New strategies, therefore, must be devised in order to limit more effectively the spread of this virus.

In this regard, three principal approaches are currently being investigated. In order to decrease susceptibility to the consequences of infection, vaccines are being sought which will induce the production of protective antibodies. (6) As treatment modalities, the use of soluble antagonists t block the receptor for HIV is being studied (7) as are pharmacologic agents such as nucleic acid analogues which can interfere with the transcription of viral genomic sequences. (8) Each of these systems has virtues and limitations, and to date none has proven completely efective.

Because heat or light in combination with drugs and dyes can inactivate viruses including HIV in vitro, (9) others have suggested the use of these forms of energy to treat AIDs patients. The results of studies using heat have not been peer reviewed and are therefore impossible to evaluate. The use of light with drugs ("photopheresis") (10) appears to be efficacious, although this treatment may be limited by drug toxicity and the potential long-term effects of ultraviolet radiation on blood cell nucleic acids. Also, by its nature, this last system may not be suitable for the treatment of tissue associated virus. As a result of our interest in the use of electric current to alter biological systems, we focused our investigations on the ability of direct electrical current at biocompatible levels to alter the infectivity of HIV for susceptible CD4 positive cells in vitro.
MATERIAL AND METHODS

Electrical Treatment of HIV

The RF strain of HIV (AIDS Reagent Program) was cryopreserved prior to treatment at -70 degrees C. For treatment, a sample of virus was thawed and maintained on ice at 4 degrees C. Ten microliters (uL) of HIV at a concentration of 10 sup.5 infectious particles per mL were placed into a chamber which included a pair of platinum electrodes 1mm apart permanently mounted into a well 1.56 mm in length and 8.32 mm in depth equal to 12.9uL volume capacity. The chamber was connected to a power supply capable of creating constant direct current. The viral aliquots were exposed to direct currents ranging form 0 micro amperes (uA) for up to 12 minutes to 100UA for up to 6 minutes. Intermediate currents of 25, 50, and 75 uA were used to expose similar viral aliquots. Under these conditions, for example, 0, 50, and 100 uA represent 0, 3.85, and 7.7 uA/mm sup.2 current densities respectively. The current was monitored throughout the experiment.

A matrix of current and time employed is shown in Table 1.

After the exposure of virus to electric current, the contents of the chamber were removed and placed into sterile micro tubes. Five uL of each sample were removed and diluted with 95 uL tissue culture medium supplemented with 10% fetal calf serum (FCS) for subsequent assays.

Syncytium-Formation Assay

This assay was performed as previously described by Nara et al. (11) Briefly, 10 sup.5 CEM-SS cells were dispensed into poly-L-lysine coated microtiter wells. Thereafter, tenfold dilutions of H9 cells incubated with the treated HIV samples were co-cultured in triplicate for up to 4 days with the CEM-SS cells. Identical wells were prepared with control uninfected and infected cells. The wells were examined for syncytium formation at 2 and 3 days and quantified using an inverted microscope.

Reverse Transcriptase Assay

Uninfected H9 cells were pelleted at 1,000 rpm for 5 minutes at room temperature, the supernatant was decanted, and the cells were resuspended in 100 uL treated viral sample. The cells were incubated for up to 6 hours with the viral samples. At the end of the incubation time,. the viral/cell suspensions were centrifuged at 1,000 rpm for 5 minutes and the supernatant decanted. The cell pellet was then resuspended in 5mL of RPMI, 10% FCS and placed into a T25 tissue culture flask and maintained at 37 degrees C, 5% COsub.2 in a humidified chamber. At 2 day intervals (beginning at day 2), 1 mL of the cell suspensions was removed from each sample and centrifuged at 1,000 rpm for 5 minutes in order to pellet the cells. The supernatant was subsequently centrifuged at 14,000 rpm for 15 minutes. the pellet was resuspended in suspension buffer and assayed using standard methodology employing Mg++ as the divalent cation, poly (rA) oligo d(T) 12-18 as template primer, and tritiated thymidine (sup.3H-TdR) which comprise the reaction mixture. Known HIV positive and negative control samples were included in each assay for reference. Thirty uL of the reaction mixture were added to each 10 uL viral sample and incubated at 37 degrees C for 60 min. Samples were then incubated with 1uL of cold quench solution on ice for 15 minutes and filtered through a Millipore manifold. Chimneys were rinsed first with wash solution and followed by cold 95% ethanol. The filters were dried by vacuum and counted in scintillation fluid. Reverse transcriptase activity is expressed as counts per minute (cpm) and is considered positive only if cpm are at least five times greater than cpm obtained with HIV-negative control samples.

Biocompatibility of Electric Currents/Time

To determine if the electric currents used were in a biocompatible range of energy, uninfected H9 cells were exposed to distinct currents for different amounts of time. The H9 cells were washed two times in Hanks Balance Salt Solution (HBSS). Thereafter, the cells were resuspended in RPMI, 10% FCS at a concentration of 10sup.(?) cells per mL. Ten uL of the cell samples were placed into the reaction chamber. The cell samples were then exposed to 0, 50, or 100 uA for 0, 3, or 6 minutes. At the end of each test, the cell sample was removed from the chamber and approximately 10 uL of the sample was mixed with 90 uL of tyrpan blue. The number of viable cells was determined by trypan blue exclusion using a hemocytometer and light microscope. Results are expressed as percentage of viable cells from the total of all cells. At least 200 cells per field were counted.

Statistical Analysis

Results of the syncytium-formation and reverse transcriptase assays were tested for statistical significance by the Student's t test and analyses of variance.

RESULTS

Syncytium-Formation Assay

Using this index of HIV infectivity, it was determined that exposing virus to direct electric current suppressed its capacity to induce the formation of syncytia. Figure 1 shows a representative experiment and Table 2 shows the group data for three separate experiments. As can be noted in Figure 1, a statistically significant (p<0.001) reduction in syncytium number was observed, and this reduction was dependent upon the current applied to the viral isolate. At three different viral dilutions, there were analogous results in that a total charge of 200 uA x min (25uA for 8 minutes) reduced the number of syncytia from 50% to 65% while a charge of 300 uA x min (50uA for 6 minutes, 75 uA for 4 minutes, or 100uA for 3 minutes) resulted in 90% reduction.

Reverse Transcriptase Assays

The direct electric currents to which HIV was exposed also reduced reverse transcriptase activity. Five separate experiments were conducted; a representative experiment is shown in Figure 2 and the group data are included in Table 3. As can be seen in Figure 2, there was a significant decrease in the amount of reverse transcriptase activity after exposure of the virus to either 50 uA for 3 or 6 minutes . An equivalent reduction in reverse transcriptase activity was also noted with exposure to 100 uA for 3 minutes. and near ablation of reverse transcriptase activity was seen with exposure of the viral isolate to 100uA for 6 minutes resulted in a 94% reduction. An analysis of variance indicates that the decrease in reverse transcriptase activity was statistically significant (p<0.001).

Biocompatibility of Electric Currents/Time

The ------(?) of a viability analysis using trypan blue exclusion criteria applied to uninfected cells exposed to the different currents and times used for these studies are shown in Table 4. The viability of H9 cells, after exposure to 100uA for either 3 or 6 minutes, did not show a significant decrease when compared to the 0 current control. After maximum treatment at 100 uA for 6 minutes, cell viability was 93% . Interestingly, in other preliminary experiments in which HIV-infected H9 cells were used, the results show that at 100 uA there may have been a significant decrease in the number of viable cells. That is, while an instantaneous pulse of 100 uA did not affect the viability of infected cells, a decrease in viability was noted at 3 and 6 minutes of exposure to 100 uA. This decrease was time-dependent in that exposure to 100 uA for 3 minutes resulted in a viability of 83% while 100 uA for 6 miutes resulted in a viability of 80%. Although theses data are provocative, they only represent a preliminary experiment and require further investigation.

With respect to the possibility that the electric current was transduced into heat, the calculated rise in termperature within the chamber was determined to be less than 1 degree C. In order to verify this, a temperature microprobe was introduced into the chamber containing tissue culture medium alone.

Results of these studies are shown in Table 5. Similar results were obtained when H9 cell-containing medium was placed in the reaction chamber. The data indicate that for the currents and times used for these experiments, there was no alternation in the temperature of the chamber.

DISCUSSION

The results repored here demonstrate that HIV treated with direct electric currents from 50 to 100 uA has a significantly reduced infectivity for susceptible cells in vitro. This reduction of infectivity correlates with the total electric charge passing through the chamber. Although extrapolation of these data predicts that ablation of HIV infectivity may be possible, and additional preliminary data support this prediction, the expectation that some virions may still excape the electrical effect cannot be discounted. Nevertheless, the therapeutic potential of electric current may reside in its ability to lower the viral titer to subclinical significance or in its incorporation into a strategy analogous to that of other therapies in which repeated cycles of treatment eventually achieve remission or cure.

The data presented in this report are based on both quantitative and quantal determinations of viral infectivity. Although the syncytium-formation assay can be used to quantify the number of infectious viral particles, this use with respect to HIV may be abridged because of the ability of free fusigenic peptide (gp41) to induce syncytia by itself. Therefore, while syncytia were observed at some dilutions of electrically treated virus, this may simply represent the presence of soluble gp41 in the tissue culture medium. We believe that the correlation between total charge and reduction in syncytium number more adequately reflects the ability of direct electric current to reduce HIV infectivity.

This belief is also suported by the results of the reverse transcriptase assays. Although a decrease in HIV reverse transcriptase does not assure reduced infectiousness of this virus for susceptible cells, we feel that, taken together with the syncytium-formation data, the results indicate that significant attenuation of HIV infectivity is achieved by treatment with direct electric currents.

With respect to the biocompatibility of the electric currents and toal charges reported here, two separate sets of evidence are applicable. The first has to do with the results showing that, by trypan blue exclusion, no significant cytotoxicity was induced in H9 cells by any total charge tested. The other evidence is obtained from reports which clearly indicate that the amount of electricity used for these experimetns is significantly below presently used therapeutic electric curents which are in the milliampere range. (12-16)

Rather than negative effects, exposure of cells to electric current may actually have positive consequences for resistance to infection in that important cellular electrochemical changes correlate with enhancement of specific enzymatic activities. In particular, a facilitation of succinate dehydrogenase (SDH) and ATPase activity has been observed. (12, 15) Both of these enzymes are associated with the oxidative capacity of the cell. Specifically, it has been suggested that an electrochemical reaction occurs between mitochondrial membrane-bound H+ ATPase and ADP leading to the formation of ATP. Therefore, exposure of cells to direct electrric currrent may directly or indirectly increase energy resources within a cell and facilitate cell metabolism. This, in turn, may actually render a cell less susceptible to the effects of viral infection.

In summary, the data presented here indicate that biocompatible direct electric current significantly reduces the infectivity of HIV. Continuing investigations are exploring the mechanisms through which this effect is mediated. The initial focus of these experiments is centered on the potential role which ionic and molecular species generated by electrolysis may have on the virus. However, the complete mechanism by which direct electric current attenuates HIV infectivity is undoubtedly far more complex than simple electrolysis. Nonetheless, and independent of a complete understanding of all of the mechanisms involved in the attenuation of HIV infectivity, the present observations may serve as an initial step for the development of new strategies to treat infection or prevent transmission of HIV through the treatment of the blood supply.

ACKNOWLEDGEMENT

The authors wish to thank Mrs. Barbara Shea for her excellent secretarial assistaince and Dr. Gabor Kemeny for important technical help. (STI)

REFERENCES

1. Sato PA, Chin J, Mann JM. REview of AIDS and HIV infection: global epidemiology and statistics. AIDS 1989; 3 Suppl; 1:S301-7.

2. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987'1 Supp 36:S1-15.

3. Thacker SB, Berkleman RI, Public health surveillance in the United States. Epidemiol Rev. 1988"10:164-90.

4. Klein RS, Friedland GH. Transmission of human immunodeficiency virus type 1 (HIV) by exposure to blood: defining the risk. Ann Int Med 1990; 113:729-30.

5. Oxtoby MJ. Epidemiology of pediatric AIDS in the UNited States. In: Kozlowski PB, Snider DA, Vietze PM, et al, ads. Brain in pediatric AIDS; 1990. p 1-8

6. Broder S, Mitsuya H, Yarchoan R, et al. Antiretroviral therapy in AIDS. Ann Int Med 1990; 113:604-18.

7. Perno CF, Baseler MW, Broder S, et al. Infection of monocytes by human immunodeficiency virus I blocked by inhibitors of CD4-gp 120 binding, even in the presence of enhancing antibiodies. J Exp Med 1990; 171:1043-56.

8. Mitsuya, H, Weinhold KJ, Furman FA, et al. 3'- Azido-3'-deoxythymidine (BW A509U): an ativiral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985; 82:7096-100.

9. Quinnan GV, Wells MA, Wittek AE, et al. INactivation of human T-cell virus, type III by heat, chemicals and irradiation. TRansfusion 1986;26:481-3.

10. Bisaccia E, Berger C, Kainer AS. Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot sutdy. Ann Int Med 1990;113:270-75.

11. Nara PL, Hatch WC, Dunlop NM, et al. Simple, rapid quantitative, syncytiumforming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retrovirus 1987;3:283-302.

12. Cheng N, VanHoof H, Bockx E, et al. The effects of electric currents on ATP generation, protein synthesis, and membrane transport in rat skin. Clin Ortho Rel Res 1983;175:263-72.

13. Frank C, Schachar N, Dittrich D, et al. Electromagnetic stimulation of ligament healing in rabbits. Clin Ortho Rel Res 1983;175:263-72.

14. Eriksson E, Hagg,arl T. comparisom opf isometric muscle training and electrical stimulation supplementing isometric muscle training in the recovery after major knee ligament surgery. Amer J Sports Med 1979;7:169-71.

15. Stanish WD, Valiant GA, Bonen A, et al. The effects of immobilization and of electrical stimulation on muscle glycogen and myofibrillar ATPase. Can J Appl Sport Sc 1982;7:267-71

16. Pilla AA. Electrochemical information transfer at living cell membranes. Ann NY Acad Sci 1974;205:148-70.

Reader Comments

Pedagogue Chides Ken Adachi & Hulda Clark for Electronics 'Error' re. Bio-electrification (April 6, 2007)
http://educate-yourself.org/lte/errorcorrection04apr07.shtml

http://educate-yourself.org/cn/LymanKaalibiocompatibleHIV1996report18nov...


Medical researchers patented AIDS cure in 1990
By Juris Doctor Boyd Graves
Forward by Jerry Mazza
Online Journal Associate Editor
Jan 21, 2008, 00:18

Email this article
Printer friendly page
I can’t think of any more fitting time than the anniversary of Dr. Martin Luther’s birthday to submit this article by Boyd Graves, an African American who has first-hand knowledge of AIDS and has sustained his life by his own research into viable cures. He has also persistently contributed to combating AIDS by submitting his findings to those in power to bring about “positive” changes in attitude towards cures at home and around the world.

As expected, he has been largely ignored, if not persistently harassed by elements in power. The below article is a perfect example, originally published on December 13, 2007, and forwarded with other materials by Dr. Graves to Speaker of the House Nancy Pilosi and Joe Leonard of the Congressional Black Caucus. In the name of Dr. King, let us assert one more time that We Shall Overcome, not just politically, but medically as well. Let there be life for our world, all of it. JM. . . .

In the Fall of 1990, two medical researchers, Drs. William Lyman and Steven Kaali, working at Albert Einstein College of Medicine in New York City made an important discovery. They found that they could inactivate the HIV virus by applying a low voltage direct current electrical potential with an extremely small current flow to AIDS infected blood in a test tube. Initially, they discovered this in the lab by inserting two platinum electrodes into a glass tube filled with HIV-1 (type 1) infected blood.

They applied a direct current to the electrodes and found that a current flow in the range of 50-100 microamperes (uA) produced the most effective results. Practically all of the HIV viral particles were adversely affected while normal blood cells remained unharmed. The viral particles were not directly destroyed by the electric current, but rather the outer protein coating of the virus was affected in such a way as to prevent the virus from producing reverse transcriptase, a necessary enzyme needed by the virus to invade human cells.

Reverse transcriptase allows the virus to enter a human T cell line (called CEM-SS) and commandeer the DNA reproduction machinery. After using the host cell to reproduce itself into thousands of new virii, the swollen host cell (now called syncytia or giant cell) will burst and spew the contents into the bloodstream or lymph system. This is how the virus spreads, but lacking reverse transcriptase, the HIV virus can't invade the host cell and it becomes vulnerable to destruction by the body's immune system. (The details of this experiment can be read from Kaali's patent application.)

A brief announcement of this discovery appeared in The Houston Post (Mar 20, 1991), then in Science News (Mar. 30, 1991 pg. 207) and later in Longevity magazine: (Dec.1992 pg. 14). Following their work in the Fall of 1990, Kaali and Lyman presented their findings at the First International Symposium on Combination Therapies (an AIDS conference) in Washington DC on March 14th, 1991. Kaali outlined two methods for treating an AIDS patient with this new therapy: One method involved removing a small amount of blood, electrifying it and then returning it to the patient's body. The second method involved sewing a miniature electrifying power supply along with two tiny electrodes directly into the lumen of an artery. For long term treatment, the mini electrifying unit needed to be removed and relocated to a new artery site after 30-45 days since scar tissue and calcification forming around the implant unit would lead to artery blockage. Kaali (along with co-inventor Peter Schwolsky) filed for a patent on this implantable electrifying device on Nov 16, 1990 and nine months later was granted patent #5,139,684 on August 18, 1992.

It's interesting to note two things here:

1. In order to obtain a patent from the United States Patent Office, Kaali and Schwolsky had to prove that the device works as claimed. Lacking solid proof, US patents are simply not granted.

2. Very often it takes years to obtain a patent, yet this patent was granted in only nine months; a further indication to me of the strength of their demonstrated claims

It's also interesting to note that other than the 3 publications mentioned above and the March '91 AIDS conference, nothing again appeared in print, radio, or TV about this important discovery as a potential treatment and cure for AIDS from Kaali and company. Most knowledgeable observers feel that Kaali and Lyman's discovery was intentionally suppressed following the March '91 AIDS conference presentation.

If AIDS research was on the level and not the sham that it actually is, this should have made front page news around the world. (Around 1999, I was contacted by a woman with AIDS who had managed to reach Dr. William Lyman over the phone. She asked him about his experiments with Kaali regarding blood electrification and if she could obtain the treatment through them. Lyman denied any knowledge of any AIDS treatment or cure. He said he never heard of Dr. Kaali and he had no idea what she was talking about concerning blood electrification and then hung up on her. What does that tell about the power of the people behind the suppression of this discovery?)

Accompanying document and addresses

Boyd Graves wrote:

They have no record of the U.S. Special Virus program (1962 - 1978). They have never mentioned the 1997 CURE for AIDS, "TETRASIL". WHY? Boyd EdGraves, J.D. 619-849-9364

Boyd Graves > wrote:

Date: Mon, 14 Jan 2008 14:14:52 -0800 (PST)

From: Boyd Graves boyded2003@yahoo.com

Subject: Africa and the U.S. AIDS CURE (patent#5676977)

To: Chairman Payne noel.lusane@mail.house.gov

CC: Speaker Nancy Pelosi wendell.primus@mail.house.gov

Senator Harry Reid carolyn_gluck@reid.senate.gov

Congressman BobFilner willie.blair@mail.house.gov. . . .

January 14, 2008

Donald Payne, Chairman

United States House Foreign Affairs Subcommittee on Africa and Global Health

United States Congress

United States of America

Re: Africa and the U.S. AIDS CURE

A Report to the United States House Foreign Affairs Subcommittee on Africa and Global Health

Dear Chairman Payne:

After contacting the Committee staff I hereby submit this request to provide testimony before Congress regarding my “Global Plan to End HIV/AIDS,” and the progress made to date.

During the year 2007, our efforts have led to the brink of clinical trials of the AIDS CURE in both Zambia and Angola. We seek the jurisdiction of the subcommittee for further oversight and direction.

In 1997, the United States patented the CURE for AIDS, U.S. patent#5676977. Go to www.uspto.gov. Part of the “Global Plan to end HIV/AIDS” is the initiation of “clinical trials” of the patented CURE for efficacy, protocol and modality. We believe this Congressional subcommittee is the appropriate Congressional authority to oversee the clinical trial testing of the ten year old patented CURE for AIDS.

Part two of the “PLAN” is a review and investigation of the U.S. Special Virus program (1962 – 1978). According to the experts, this federal program lies at the heart of the origin of HIV/AIDS. Specifically, the U.S. Special Virus program made the esp-1 virus in 1971. Under electron microscope, the esp-1 virus is identical to HIV. This point is further underscored when you compare the 1971 electron microscope of the esp-1 virus to the 2008 government HIV/AIDS poster, “Understanding HIV and AIDS.”

Mr. Chairman, how can the 2008 government poster of HIV/AIDS be identical to a photo from 1971? Further still, Congress funded the development of HIV/AIDS on June 9, 1969. See, U.S. House Resolution 15090, page 129.

The record reveals Congress funded the development of HIV/AIDS as early as May 1946. See, “Better” Than the Bomb, Time Magazine, June 3, 1946.

The record reveals that HIV/AIDS is a product of recombinant genetics, best highlighted by the “sheep” cells in its genome. The “visna” sheep cells alone PROVE HIV/AIDS is a synthetic biological agent EXACTLY as requested by the U.S. Pentagon on June 9, 1969. See, Science, Vol. 227, pp. 173 – 7, January 1985, see also, PROC NAS, Vol. 83, pp. 4007 – 11, June 1986, PROC NAS, Vol. 92, 3283 – 87, April 11, 1995.

According to the Proceedings of the United States of America, HIV/AIDS evolved from an “Icelandic” sheep disease! In fact the very strain is from 1932 (strain ks-1514). When we began giving syphilis to African Americans, we also began testing the infectious agent of HIV/AIDS on the sheep in Iceland. Tuskegee was not an isolated event!

In any testimony before your Committee we can conclude the evidence confirms HIV/AIDS is the result of a century long hunt for a contagious cancer that selectively kills. We also conclude the clinical trials of the patented CURE for AIDS should begin immediately as the health of Africa and the world begins the process of recovery from the greatest man made calamity in the history of the known world.

Respectfully submitted,

Boyd Ed Graves, J.D.
574 Garret Avenue
Chula Vista, CA 91910
619-849-9364
www.boydgraves.com
www.boydgraves.com/graves (bio)
www.boydgraves.com/comments/ (expert reviews)

cc: Nancy Pelosi, House Speaker

Joe Leonard, Congressional Black Caucus

Jerry Mazza is a freelance writer living in New York City. Reach him at gvmaz@verizon.net.
Copyright © 1998-2007 Online Journal
Email Online Journal Editor

The United States Special Virus Program (1962-1978) is a formerly secret federal virus development initiative to develop a contagious cancer that selectively kills based on genetic ethnic markers of the host. The U.S. Special Virus Program published 15 annual progress reports detailing the progression of manipulating animal viruses to infect human hosts. Each progress report details the progress of 'special virus' scientists including Dr. Robert Gallo and Dr. Duesberg as they work towards their contracted goal to create the 'special virus'. What makes a virus special?

The U.S. Special Virus Progress Reports represent 15 years of missing medical and scientific history. The progress reports detail every experiment, contract and accomplishment toward the government's search for their 'Special Virus'. While the U.S. Special Virus Program may be found in the World Catalog Database, finding the actual reports is a challenging occasion even for a professional researcher. Several copies of the U.S. Special Virus Progress Reports, we have recovered from university science library shelves; however, six of the reports remain 'missing' and even some of the nine copies known to exist at the National Cancer Institute's archives, have recently 'disappeared' from government shelves.

This page is dedicated toward the preservation, study and distribution of these formerly secret and rare documents. This collection of U.S. Special Virus documents is the result of over 15 years of research by AIDS activist, Dr. Boyd E. Graves. Dr. Graves archives of U.S. Special Virus documents represents the largest known collection of U.S. Special Virus documents in the world.

"These progress reports tell the whole story about the development of HIV/AIDS," Graves said. "This goverment needs accountability."

All documents are hi-res scans of actual government documents. Our Special Virus reproductions are available to order in print; however, our electronic document archives are provided to the international reading public free of charge because of the critical importance of ending HIV/AIDS and responsibility to preventing future biological assaults via covert federal virus programs.

As Dr. Graves says, "The progress reports have eyes."

Please utilize these documents wisely.

The links to these reports in .pdf here will now provide immediate global digital access to interested persons saving researchers time and expense. The reports require the free Adobe Acrobat to view. May these pages be downloaded so much as to crash already overloaded servers. Please direct your questions and comments to me personally at endaidstoday@yahoo.com

Sincerely,

Joel Bales, Activist/Archivist/Publisher